5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide

C106H128F6N32O8 — CID 159408547

IUPAC5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide
SMILESCN(C)c1ccc(C(=O)C[C@H]2CN(c3cnc(C(N)=O)c(Nc4ccn(C)c4)n3)CC(F)(F)C2)cc1.CN(C)c1ccc(C(=O)C[C@H]2CN(c3cnc(C(N)=O)c(Nc4cnn(C5CC5)c4)n3)CC(F)(F)C2)cc1.C[C@@H]1[C@H](CC(=O)c2ccc(C3CC3)cc2)CCCN1c1cnc(C(N)=O)c(Nc2cnn(CCN(C)C)c2)n1.C[C@@H]1[C@H](CC(=O)c2ccc(N(C)C)cc2)C(F)(F)CCN1c1nnc(C(N)=O)c(Nc2cnn(C3CC3)c2)n1
InChIInChI=1S/C29H38N8O2.C26H31F2N9O2.C26H30F2N8O2.C25H29F2N7O2/c1-19-23(15-25(38)22-10-8-21(9-11-22)20-6-7-20)5-4-12-37(19)26-17-31-27(28(30)39)29(34-26)33-24-16-32-36(18-24)14-13-35(2)3;1-15-20(12-21(38)16-4-6-18(7-5-16)35(2)3)26(27,28)10-11-36(15)25-32-24(22(23(29)39)33-34-25)31-17-13-30-37(14-17)19-8-9-19;1-34(2)19-5-3-17(4-6-19)21(37)9-16-10-26(27,28)15-35(13-16)22-12-30-23(24(29)38)25(33-22)32-18-11-31-36(14-18)20-7-8-20;1-32(2)19-6-4-17(5-7-19)20(35)10-16-11-25(26,27)15-34(13-16)21-12-29-22(23(28)36)24(31-21)30-18-8-9-33(3)14-18/h8-11,16-20,23H,4-7,12-15H2,1-3H3,(H2,30,39)(H,33,34);4-7,13-15,19-20H,8-12H2,1-3H3,(H2,29,39)(H,31,32,34);3-6,11-12,14,16,20H,7-10,13,15H2,1-2H3,(H2,29,38)(H,32,33);4-9,12,14,16H,10-11,13,15H2,1-3H3,(H2,28,36)(H,30,31)/t19-,23+;15-,20+;2*16-/m1111/s1
InChIKeyLOGWMBISVAUCCE-NWRWXAHOSA-N
MW2092.39 g/mol
LogP14.38
Rot. Bonds37

About 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide

5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide (PubChem CID 159408547) has the molecular formula C106H128F6N32O8 and a molecular weight of 2092.39 g/mol. Its IUPAC name is 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide.

Molecular Properties

Compound Name5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide
PubChem CID159408547
Molecular FormulaC106H128F6N32O8
Molecular Weight2092.39 g/mol
Exact Mass2091.05
IUPAC Name5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide
SMILESCN(C)c1ccc(C(=O)C[C@H]2CN(c3cnc(C(N)=O)c(Nc4ccn(C)c4)n3)CC(F)(F)C2)cc1.CN(C)c1ccc(C(=O)C[C@H]2CN(c3cnc(C(N)=O)c(Nc4cnn(C5CC5)c4)n3)CC(F)(F)C2)cc1.C[C@@H]1[C@H](CC(=O)c2ccc(C3CC3)cc2)CCCN1c1cnc(C(N)=O)c(Nc2cnn(CCN(C)C)c2)n1.C[C@@H]1[C@H](CC(=O)c2ccc(N(C)C)cc2)C(F)(F)CCN1c1nnc(C(N)=O)c(Nc2cnn(C3CC3)c2)n1
InChIInChI=1S/C29H38N8O2.C26H31F2N9O2.C26H30F2N8O2.C25H29F2N7O2/c1-19-23(15-25(38)22-10-8-21(9-11-22)20-6-7-20)5-4-12-37(19)26-17-31-27(28(30)39)29(34-26)33-24-16-32-36(18-24)14-13-35(2)3;1-15-20(12-21(38)16-4-6-18(7-5-16)35(2)3)26(27,28)10-11-36(15)25-32-24(22(23(29)39)33-34-25)31-17-13-30-37(14-17)19-8-9-19;1-34(2)19-5-3-17(4-6-19)21(37)9-16-10-26(27,28)15-35(13-16)22-12-30-23(24(29)38)25(33-22)32-18-11-31-36(14-18)20-7-8-20;1-32(2)19-6-4-17(5-7-19)20(35)10-16-11-25(26,27)15-34(13-16)21-12-29-22(23(28)36)24(31-21)30-18-8-9-33(3)14-18/h8-11,16-20,23H,4-7,12-15H2,1-3H3,(H2,30,39)(H,33,34);4-7,13-15,19-20H,8-12H2,1-3H3,(H2,29,39)(H,31,32,34);3-6,11-12,14,16,20H,7-10,13,15H2,1-2H3,(H2,29,38)(H,32,33);4-9,12,14,16H,10-11,13,15H2,1-3H3,(H2,28,36)(H,30,31)/t19-,23+;15-,20+;2*16-/m1111/s1
InChIKeyLOGWMBISVAUCCE-NWRWXAHOSA-N
XLogP14.38
TPSA489.08 Ų
H-Bond Donors8
H-Bond Acceptors36
Rotatable Bonds37
Heavy Atoms152
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002092.39
LogP ≤ 514.38
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1036

Analyze 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-[(2R,3S)-3-[2-(4-cyclopropyl-2-fluorophenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide
CID 158790760
5-[(2R,3S)-3-[2-(2-chloro-4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide
CID 158790761
5-[(2R,3S)-3-[2-(5-cyclopropyl-2-pyridinyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
CID 161025913
5-[(2R,3S)-3-[2-[4-(2-hydroxypropan-2-yl)-3-methylphenyl]-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
CID 157089671
3-[(2R,3R)-3-[[6-(dimethylamino)pyridine-3-carbonyl]amino]-2-methylpiperidin-1-yl]-5-[(1-ethylpyrazol-4-yl)amino]-1,2,4-triazine-6-carboxamide
CID 140930412
5-[(3R)-3-[(4-cyclopropylbenzoyl)amino]-3-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
CID 146835383
5-[(2R,3S)-3-[2-(5-cyclopropyl-2-pyridinyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[5-(4-methylpiperazin-1-yl)-2-pyridinyl]amino]pyrazine-2-carboxamide
CID 147867993
5-[(2R,3S)-3-[2-(4-cyclopropyl-2-fluorophenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[4-(4-methylpiperazin-1-yl)anilino]pyrazine-2-carboxamide
CID 159103982
5-[(2R,3S)-3-[2-(4-cyclopropyl-2-fluorophenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-3-yl)amino]pyrazine-2-carboxamide
CID 158517171
3-[4-(1-cyclopentyl-4-methylpiperidin-4-yl)anilino]-5-[(2R,3S)-3-[2-(dimethylamino)-2-oxoethyl]-2-methylpiperidin-1-yl]pyrazine-2-carboxamide
CID 158937659
5-[(3R)-3-[(4-cyclopropylbenzoyl)amino]piperidin-1-yl]-3-[4-(4,4-difluoropiperidin-1-yl)anilino]pyrazine-2-carboxamide
CID 145201377
3-[4-(1-cyclopentylpiperidin-4-yl)anilino]-5-[(3R)-3-(dimethylsulfamoylmethyl)piperidin-1-yl]pyrazine-2-carboxamide
CID 159998183

Frequently Asked Questions

What is the IUPAC name of 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide?
The IUPAC name of 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide (CID 159408547) is 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide.
What is the SMILES notation for 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide?
The canonical SMILES for 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide is CN(C)c1ccc(C(=O)C[C@H]2CN(c3cnc(C(N)=O)c(Nc4ccn(C)c4)n3)CC(F)(F)C2)cc1.CN(C)c1ccc(C(=O)C[C@H]2CN(c3cnc(C(N)=O)c(Nc4cnn(C5CC5)c4)n3)CC(F)(F)C2)cc1.C[C@@H]1[C@H](CC(=O)c2ccc(C3CC3)cc2)CCCN1c1cnc(C(N)=O)c(Nc2cnn(CCN(C)C)c2)n1.C[C@@H]1[C@H](CC(=O)c2ccc(N(C)C)cc2)C(F)(F)CCN1c1nnc(C(N)=O)c(Nc2cnn(C3CC3)c2)n1.
What is the InChIKey of 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide?
The InChIKey is LOGWMBISVAUCCE-NWRWXAHOSA-N. The full InChI is InChI=1S/C29H38N8O2.C26H31F2N9O2.C26H30F2N8O2.C25H29F2N7O2/c1-19-23(15-25(38)22-10-8-21(9-11-22)20-6-7-20)5-4-12-37(19)26-17-31-27(28(30)39)29(34-26)33-24-16-32-36(18-24)14-13-35(2)3;1-15-20(12-21(38)16-4-6-18(7-5-16)35(2)3)26(27,28)10-11-36(15)25-32-24(22(23(29)39)33-34-25)31-17-13-30-37(14-17)19-8-9-19;1-34(2)19-5-3-17(4-6-19)21(37)9-16-10-26(27,28)15-35(13-16)22-12-30-23(24(29)38)25(33-22)32-18-11-31-36(14-18)20-7-8-20;1-32(2)19-6-4-17(5-7-19)20(35)10-16-11-25(26,27)15-34(13-16)21-12-29-22(23(28)36)24(31-21)30-18-8-9-33(3)14-18/h8-11,16-20,23H,4-7,12-15H2,1-3H3,(H2,30,39)(H,33,34);4-7,13-15,19-20H,8-12H2,1-3H3,(H2,29,39)(H,31,32,34);3-6,11-12,14,16,20H,7-10,13,15H2,1-2H3,(H2,29,38)(H,32,33);4-9,12,14,16H,10-11,13,15H2,1-3H3,(H2,28,36)(H,30,31)/t19-,23+;15-,20+;2*16-/m1111/s1.
What are the key properties of 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide?
5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide has a molecular weight of 2092.39 g/mol, XLogP of 14.38, 37 rotatable bonds, 8 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(2R,3S)-3-[2-(4-cyclopropylphenyl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]amino]pyrazine-2-carboxamide;5-[(1-cyclopropylpyrazol-4-yl)amino]-3-[(2R,3S)-3-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-4,4-difluoro-2-methylpiperidin-1-yl]-1,2,4-triazine-6-carboxamide;3-[(1-cyclopropylpyrazol-4-yl)amino]-5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]pyrazine-2-carboxamide;5-[(5R)-5-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrrol-3-yl)amino]pyrazine-2-carboxamide is sourced from PubChem (CID 159408547), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).